Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Related Articles by Review for PubMed (Select 12152785)

1.

Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms.

Perry A, Kunz SN, Fuller CE, Banerjee R, Marley EF, Liapis H, Watson MA, Gutmann DH.

J Neuropathol Exp Neurol. 2002 Aug;61(8):702-9.

PMID:
12152785
2.
4.

Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis.

Woodruff JM.

Am J Med Genet. 1999 Mar 26;89(1):23-30. Review.

PMID:
10469433
5.

Neoplasms with neural differentiation: a review. Part II: Malignant neoplasms.

Sangüeza OP, Requena L.

Am J Dermatopathol. 1998 Feb;20(1):89-102. Review.

PMID:
9504678
6.

Malignant peripheral nerve sheath tumors: an update.

Fuchs B, Spinner RJ, Rock MG.

J Surg Orthop Adv. 2005 Winter;14(4):168-74. Review.

PMID:
16442014
7.

Intraosseous malignant peripheral nerve sheath tumor in a patient with neurofibromatosis.

Terry DG, Sauser DD, Gordon MD.

Skeletal Radiol. 1998 Jun;27(6):346-9. Review.

PMID:
9677654
8.

Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways.

Katz D, Lazar A, Lev D.

Expert Rev Mol Med. 2009 Oct 19;11:e30. doi: 10.1017/S1462399409001227. Review.

PMID:
19835664
9.

Genetic basis of tumorigenesis in NF1 malignant peripheral nerve sheath tumors.

Upadhyaya M.

Front Biosci (Landmark Ed). 2011 Jan 1;16:937-51. Review.

PMID:
21196210
10.

Malignant peripheral nerve sheath tumors.

Gupta G, Maniker A.

Neurosurg Focus. 2007 Jun 15;22(6):E12. Review.

PMID:
17613203
11.

Malignant Peripheral Nerve Sheath Tumor: molecular pathogenesis and current management considerations.

Grobmyer SR, Reith JD, Shahlaee A, Bush CH, Hochwald SN.

J Surg Oncol. 2008 Mar 15;97(4):340-9. doi: 10.1002/jso.20971. Review.

PMID:
18286466
12.

Genetics of neurofibromatosis 1-associated peripheral nerve sheath tumors.

Stephens K.

Cancer Invest. 2003;21(6):897-914. Review.

PMID:
14735694
13.

Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.

Kolberg M, Høland M, Agesen TH, Brekke HR, Liestøl K, Hall KS, Mertens F, Picci P, Smeland S, Lothe RA.

Neuro Oncol. 2013 Feb;15(2):135-47. doi: 10.1093/neuonc/nos287. Epub 2012 Nov 15. Review.

14.

Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Carroll SL.

Acta Neuropathol. 2012 Mar;123(3):321-48. doi: 10.1007/s00401-011-0928-6. Epub 2011 Dec 11. Review.

15.
16.

Genomic and molecular aberrations in malignant peripheral nerve sheath tumor and their roles in personalized target therapy.

Yang J, Du X.

Surg Oncol. 2013 Sep;22(3):e53-7. doi: 10.1016/j.suronc.2013.06.003. Epub 2013 Jul 3. Review.

PMID:
23830351
17.

Sporadic primary malignant intracerebral nerve sheath tumors: case report and literature review.

Barnard ZR, Agarwalla PK, Jeyaretna DS, Farrell CJ, Gerstner ER, Tian D, Curry WT Jr.

J Neurooncol. 2011 Sep;104(2):605-10. doi: 10.1007/s11060-011-0531-7. Epub 2011 Feb 15. Review.

PMID:
21327709
18.

Interphase cytogenetics: at the interface of genetics and morphology.

Ghadimi BM, Heselmeyer-Haddad K, Auer G, Ried T.

Anal Cell Pathol. 1999;19(1):3-6. Review. No abstract available.

PMID:
10661620
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk